Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced patent CN101298413A details a high-yield route to 3-methylcyclopentadecanone. Discover cost-effective manufacturing and scalable supply solutions for premium synthetic musk.
Patent CN117756761B reveals efficient benzofuranone synthesis. Delivers high-purity agrochemical intermediates with optimized supply chain reliability and cost reduction.
Patent CN117757876A reveals double-enzyme catalysis for 2'-F-dAR. Offers simplified process, cost reduction in pharmaceutical intermediates manufacturing, and high purity.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Novel rhodium-catalyzed pathway enhances purity and yield for sitagliptin intermediates, offering significant supply chain stability and cost reduction potential.
Novel patent CN109053652A offers high-purity Amiodarone intermediate synthesis with improved yield and scalability for global supply chains.
Patent CN102249949A details a scalable route from gamma-butyrolactone. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with our advanced process.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Efficient Lewis acid catalyzed synthesis of Marmycin A derivatives. High regioselectivity and yield for pharmaceutical intermediates targeting topoisomerase inhibition.
Patent CN107201355B details a novel phenylalanine deaminase mutant enabling cost-effective, high-purity D-phenylalanine production via single-step enzymatic catalysis.
Patent CN1045086C reveals a solvent-free thiocarbamate synthesis method eliminating phase transfer catalysts, offering significant cost reduction and supply chain reliability for mining reagent manufacturers.
Patent CN113620876B details a high-yield synthesis route for 5-methoxy laudanosine offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel pyridine-amide-oxazoline ligands for asymmetric hydroboration. High yield synthesis over 80 percent. Reliable supplier for pharma intermediates.
Patent CN115108875A reveals a metal-free visible light asymmetric method for synthesizing nitrogen-containing chiral cyclic alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN119614533B reveals thermostable enzyme mutants improving R-chiral amine synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN107382644B details a novel Pd-B co-catalyzed asymmetric method for chiral tertiary alcohols, offering high ee and mild conditions for antifungal drug manufacturing.
Patent CN1972898A details a novel Rh-catalyzed asymmetric hydrogenation process for unprotected beta-amino acids, offering significant cost reduction and streamlined API manufacturing.
Novel immobilized enzyme method for ATP synthesis ensures stable quality and cost efficiency. Ideal for pharmaceutical intermediates supply chain optimization and large scale production.
Patent CN108047172B details a novel catalytic method for converting biomass-based levulinic acid into high-purity pharmaceutical intermediates with improved yield.
Patent CN107129470A details safer Minoxidil synthesis. Reduces hazards and improves purity for pharmaceutical intermediates manufacturing supply chains.